WHO revises CD4 count policy under new diagnostics-focused guidelines
This article was originally published in Clinica
The World Health Organization (WHO) has revised the threshold at which HIV patients should be considered eligible for treatment. It is one of a series of "key recommendations" for improving HIV care, that hinge on an expanded role for laboratory testing.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.